Blocking the JNK1/2 and p38 signalling pathway with a pharmacological agent delays the transition towards heart failure,33, 34 while the over‐activation of p38 and JNK1/2 induced cardiac dilation and dysfunction.35, 36. This evidence concerns the gene MAPK8 and heart failure.